Sera Prognostics (SERA) Receivables - Other (2021 - 2025)

Sera Prognostics' (SERA) quarterly Receivables - Other came in at -$19000.0 in Q2 2025, down 200.0% on a QoQ basis from $19000.0 in Q4 2024.

Sera Prognostics (SERA) Receivables - Other (2021 - 2025) Analysis & Trends

Sera Prognostics (SERA) has 5 years of Receivables - Other data on file, last reported at -$19000.0 in Q2 2025.

Quarterly Receivables - Other changed N/A year-over-year to -$19000.0 in Q2 2025, while the trailing twelve-month figure through Dec 2025 was -$19000.0 (up 99.68% YoY) and the FY2025 annual result came in at -$19000.0, up 99.83% from the prior year.
Receivables - Other eased to -$19000.0 in Q2 2025, from $19000.0 in the prior quarter.
In the past five years, Receivables - Other ranged from a high of $11.3 million in Q4 2023 to a low of -$11.3 million in Q1 2024.
A 5-year average of $6111.1 and a median of $19000.0 in 2024 frame the typical range for Receivables - Other.
Annual changes were most pronounced in 2022 — Receivables - Other soared 92.55% — and 2024, when it sank 99.83%.
Tracing SERA's Receivables - Other over 5 years: stood at $3.1 million in 2021, then soared by 92.55% to $6.0 million in 2022, then soared by 88.5% to $11.3 million in 2023, then slumped by 99.83% to $19000.0 in 2024, then slumped by 200.0% to -$19000.0 in 2025.
The last three Receivables - Other figures came in at -$19000.0 (Q2 2025), $19000.0 (Q4 2024), and -$11.3 million (Q1 2024), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn
10	Sera Prognostics	103.48 Mn	103.48 Mn	-20,000.00

Download Data